Malik Rajesh
CIK 0001706853 Name as filed on the most recent filing
Filed as Malik Rajesh (28)
40 transaction lines · from 28 filings · filed 2018-01-17 to 2024-07-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
40 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-07-05 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 2,475 disposed | 2.51 | 6,206.56 | Form 4, filing 0001562180-24-005658 | |
| 2024-05-13 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 8,151 disposed | 4.79 | 39,033.51 | Form 4, filing 0001562180-24-004058 | |
| 2024-02-12 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 28,600 disposed | 4.62 | 132,143.44 | Form 4, filing 0001562180-24-001296 | |
| 2024-01-04 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 721 disposed | 2.94 | 2,121.40 | Form 4, filing 0001562180-24-000326 | |
| 2024-01-03 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 2,261 disposed | 3.12 | 7,051.83 | Form 4, filing 0001562180-24-000326 | |
| 2024-01-03 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 758 disposed | 3.12 | 2,364.13 | Form 4, filing 0001562180-24-000326 | |
| 2023-12-11 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 21,439 disposed | 3.06 | 65,659.08 | Form 4, filing 0001562180-23-008346 | |
| 2023-12-11 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 12,400 disposed | 4.02 | 49,862.88 | Form 4, filing 0001562180-23-008346 | |
| 2023-07-05 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 1,361 disposed | 2.45 | 3,339.49 | Form 4, filing 0001562180-23-005813 | |
| 2023-01-05 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 729 disposed | 5.41 | 3,942.07 | Form 4, filing 0001562180-23-000252 | |
| 2023-01-04 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 1,639 disposed | 5.58 | 9,138.41 | Form 4, filing 0001562180-23-000252 | |
| 2022-11-28 |
Point Biopharma Global Inc. PNT |
P, Open-market purchase | 3,700 acquired | 6.66 | 24,642.00 | Form 4, filing 0001104659-22-122390 | |
| 2022-09-13 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 18,000 disposed | 15.71 | 282,745.80 | Form 4, filing 0001562180-22-006701 | |
| 2022-07-05 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 648 disposed | 5.17 | 3,351.13 | Form 4, filing 0001562180-22-005555 | |
| 2022-01-05 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 1,445 disposed | 10.61 | 15,333.62 | Form 4, filing 0001562180-22-000305 | |
| 2021-04-22 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 15,000 disposed | 22.07 | 331,099.50 | Form 4, filing 0001562180-21-002929 | |
| 2021-03-23 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 15,000 disposed | 21.94 | 329,059.50 | Form 4, filing 0001562180-21-002425 | |
| 2021-03-02 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 15,000 disposed | 22.95 | 344,191.50 | Form 4, filing 0001562180-21-001988 | |
| 2021-01-22 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 15,000 disposed | 20.64 | 309,591.00 | Form 4, filing 0001562180-21-000488 | |
| 2020-12-10 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 9,000 disposed | 20.06 | 180,549.90 | Form 4, filing 0001562180-20-007212 | |
| 2018-12-17 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,776 disposed | 30.00 | 113,280.00 | Form 4, filing 0001562180-18-004984 | |
| 2018-11-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,529 disposed | 39.71 | 140,147.18 | Form 4, filing 0001562180-18-004595 | |
| 2018-11-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 247 disposed | 40.31 | 9,957.56 | Form 4, filing 0001562180-18-004595 | |
| 2018-10-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 2,833 disposed | 42.01 | 119,018.58 | Form 4, filing 0001562180-18-004219 | |
| 2018-10-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 943 disposed | 40.80 | 38,478.27 | Form 4, filing 0001562180-18-004219 | |
| 2018-09-17 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 2,992 disposed | 65.78 | 196,799.70 | Form 4, filing 0001562180-18-003987 | |
| 2018-09-17 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 484 disposed | 66.77 | 32,317.02 | Form 4, filing 0001562180-18-003987 | |
| 2018-09-17 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 300 disposed | 67.95 | 20,385.00 | Form 4, filing 0001562180-18-003987 | |
| 2018-08-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 2,076 disposed | 55.38 | 114,973.65 | Form 4, filing 0001562180-18-003667 | |
| 2018-08-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 1,700 disposed | 56.50 | 96,048.98 | Form 4, filing 0001562180-18-003667 | |
| 2018-07-16 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 2,514 disposed | 41.91 | 105,359.23 | Form 4, filing 0001562180-18-003318 | |
| 2018-07-16 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 1,262 disposed | 42.70 | 53,888.41 | Form 4, filing 0001562180-18-003318 | |
| 2018-06-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,776 disposed | 44.31 | 167,326.27 | Form 4, filing 0001562180-18-003027 | |
| 2018-05-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,676 disposed | 46.29 | 170,154.32 | Form 4, filing 0001562180-18-002514 | |
| 2018-05-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 100 disposed | 46.67 | 4,667.00 | Form 4, filing 0001562180-18-002514 | |
| 2018-04-16 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,276 disposed | 35.95 | 117,779.73 | Form 4, filing 0001562180-18-001896 | |
| 2018-04-16 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 500 disposed | 36.71 | 18,355.00 | Form 4, filing 0001562180-18-001896 | |
| 2018-03-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,776 disposed | 38.18 | 144,151.44 | Form 4, filing 0001562180-18-001642 | |
| 2018-02-15 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,776 disposed | 20.00 | 75,520.00 | Form 4, filing 0001562180-18-001025 | |
| 2018-01-16 |
G1 Therapeutics, Inc. GTHX |
S, Open-market sale | 3,776 disposed | 22.96 | 86,693.18 | Form 4, filing 0001562180-18-000324 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 39
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Malik Rajesh, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001706853
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6